Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 54, 2019 - Issue 10
Submit an article Journal homepage
624
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Plasma calprotectin is superior to serum calprotectin as a biomarker of intestinal inflammation in ulcerative Colitis

Mikkel MalhamThe Paediatric Department, Copenhagen University Hospital, Hvidovre, Denmark; Correspondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-6956-7676
ORCID Icon,
Katrine CarlsenThe Paediatric Department, Copenhagen University Hospital, Hvidovre, Denmark;
,
Lene RiisThe Department of Pathology, Copenhagen University Hospital, Herlev, Denmark;
,
Anders PaerregaardThe Paediatric Department, Copenhagen University Hospital, Hvidovre, Denmark;
,
Ida VindThe Gastro Unit, Medical Division, Copenhagen University Hospital, Hvidovre, Denmark;
,
Mogens FengerDepartment of Clinical Biochemistry, Copenhagen University Hospital, Hvidovre, Denmark
&
Vibeke WewerThe Paediatric Department, Copenhagen University Hospital, Hvidovre, Denmark;
show all
Pages 1214-1219 | Received 30 Jul 2019, Accepted 03 Sep 2019, Published online: 17 Sep 2019

References

  • Mosli MH, Zou G, Garg SK, et al. C-Reactive protein, fecal calprotectin, and stool lactoferrin for detection of endoscopic activity in symptomatic inflammatory bowel disease patients: a systematic review and Meta-Analysis. Am J Gastroenterol. 2015;110(6):802–819.
  • Degraeuwe P, Beld M, Ashorn M, et al. Faecal calprotectin in suspected paediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2015;60(3):339–346.
  • Carlsen K, Riis LB, Elsberg H, et al. The sensitivity of fecal calprotectin in predicting deep remission in ulcerative colitis. Scand J Gastroenterol. 2018;53(7):825–830.
  • Gaudin P, Bernardy C, Trocme C, et al. Systemic calprotectin and chronic inflammatory rheumatic diseases. Jt Bone Spine. 2019;pii: S1297-319X(18)30340–30343.
  • Fukunaga S, Kuwaki K, Mitsuyama K, et al. Detection of calprotectin in inflammatory bowel disease: Fecal and serum levels and immunohistochemical localization. Int J Mol Med. 2018;41(1):107–118.
  • Boschetti G, Garnero P, Moussata D, et al. Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn’s disease. Inflamm Bowel Dis. 2015;21(2):331–336.
  • Leach ST, Yang Z, Messina I, et al. Serum and mucosal S100 proteins, calprotectin (S100A8/S100A9) and S100A12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol. 2007;42(11):1321–1331.
  • Carlsen K, Malham M, Hansen LF, et al. Serum calprotectin in adolescents with inflammatory bowel disease - a pilot investigation. J Pediatr Gastroenterol Nutr. 2019;68(5):669–675.
  • Meuwis M-A, Vernier-Massouille G, Grimaud JC, et al. Serum calprotectin as a biomarker for Crohn’s disease. J Crohns Colitis. 2013;7(12):e678–83.
  • Kalla R, Kennedy NA, Ventham NT, et al. Serum calprotectin: a novel diagnostic and prognostic marker in inflammatory bowel diseases. Am J Gastroenterol. 2016;111(12):1796–1805.
  • Asberg A, Lofblad L, Felic A, et al. Measuring calprotectin in plasma and blood with a fully automated turbidimetric assay. Scand J Clin Lab Invest. 2019;79(1–2):50–57.
  • Nordal HH, Fagerhol MK, Halse AK, et al. Calprotectin (S100A8/A9) should preferably be measured in EDTA-plasma; results from a longitudinal study of patients with rheumatoid arthritis. Scand J Clin Lab Invest. 2018;78(1–2):102–108.
  • Turner D, Otley AR, Mack D, et al. Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study. Gastroenterology. 2007;133(2):423–432.
  • Walmsley RS, Ayres RC, Pounder RE, et al. A simple clinical colitis activity index. Gut. 1998;43(1):29–32.
  • Walsh AJ, Ghosh A, Brain AO, et al. Comparing disease activity indices in ulcerative colitis. J Crohns Colitis. 2014;8(4):318–325.
  • Travis S, Schnell D, Krzeski P, et al. Reliability and initial validation of the ulcerative colitis endoscopic index of severity. Gastroenterology. 2013;145(5):987–995.
  • Ikeya K, Hanai H, Sugimoto K, et al. The ulcerative colitis endoscopic index of severity more accurately reflects clinical outcomes and Long-term prognosis than the mayo endoscopic score. J Crohns Colitis. 2016;10(3):286–295.
  • Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006;55(6):749–753.
  • Brahmania M, Bernstein CN. Physician global assessments or blood tests do not predict mucosal healing in ulcerative colitis. Can J Gastroenterol Hepatol. 2014;28(6):325–329.
  • Walsh AJ, Bryant RV, Travis S. Current best practice for disease activity assessment in IBD. Nat Rev Gastroenterol Hepatol. 2016;13(10):567–579.
  • Falvey JD, Hoskin T, Meijer B, et al. Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission. Inflamm Bowel Dis. 2015;21(4):824–831.
  • Peyrin-Biroulet L, Bressenot A, Kampman W. Histologic remission: the ultimate therapeutic goal in ulcerative colitis? Clin Gastroenterol Hepatol. 2014;12(6):929–934.e2.
  • Sipponen T, Karkkainen P, Savilahti E, et al. Correlation of faecal calprotectin and lactoferrin with an endoscopic score for Crohn’s disease and histological findings. Aliment Pharmacol Ther. 2008;28(10):1221–1229.
  • Stawczyk-Eder K, Eder P, Lykowska-Szuber L, et al. Is faecal calprotectin equally useful in all Crohn’s disease locations? A prospective, comparative study. Arch Med Sci. 2015;11(2):353–361.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.